Related references
Note: Only part of the references are listed.Bispecific antibodies for the treatment of hemophilia A
Midori Shima
EXPERT OPINION ON BIOLOGICAL THERAPY (2022)
Safety evaluation of emicizumab prophylaxis in individuals with haemophilia A
Cassandra P. Wang et al.
EXPERT OPINION ON DRUG SAFETY (2021)
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies
Mark W. Skinner et al.
HAEMOPHILIA (2021)
Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis
Shangyi Hui et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2021)
Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers
Richard Gooding et al.
JOURNAL OF BLOOD MEDICINE (2021)
Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study
Maissa Janbain et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Effect of Tranexamic Acid on Coagulation and Fibrin Clot Properties in Children Undergoing Craniofacial Surgery
Christian Fenger-Eriksen et al.
THROMBOSIS AND HAEMOSTASIS (2020)
A hemophilia A mouse model for the in vivo assessment of emicizumab function
Stephen Ferriere et al.
BLOOD (2020)
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra®): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP)
Sophie Susen et al.
HAEMOPHILIA (2019)
Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia
Ze Yu Huang et al.
BMC MUSCULOSKELETAL DISORDERS (2019)
Design and characterization of an APC-specific serpin for the treatment of hemophilia
Stephanie G. I. Polderdijk et al.
BLOOD (2017)
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A
Catherine J. Rea et al.
ANNALS OF HEMATOLOGY (2014)
Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience
M. Holmstrom et al.
HAEMOPHILIA (2012)
Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots
Y. Dargaud et al.
HAEMOPHILIA (2011)
Towards a standardization of the murine tail bleeding model
T. K. Greene et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Monitoring platelet dependent thrombin generation in mice
Yesim Dargaud et al.
THROMBOSIS RESEARCH (2010)
Thrombin generation and fibrin clot structure
Alisa S. Wolberg
BLOOD REVIEWS (2007)
Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery
RJ Porte et al.
DRUGS (2002)